Design, synthesis and structure-activity relationships of a series of 9-substituted adenine derivatives as selective phosphodiesterase type-4 inhibitors

By Raboisson P.   Lugnier C.   Muller C.   Reimund J.-M.   Schultz D.   Pinna G.   Le Bec A.   Basaran H.   Desaubry L.   Gaudiot F.   Seloum M.   Bourguignon J.-J.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 2, 2003-02 ,pp. : 199-214

Elsevier

Access to resources Recommend Favorite

Levels of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 mRNAs in Patients with Primary Hypertension or Hypertension-induced Atherosclerosis

By Su W   Gao F   Lu J   Wu W   Zhou G   Lu S  

The Journal of International Medical Research, Vol. 40, Iss. 3, 2012-05 ,pp. : 986-994

Field House Publishing

Access to resources Recommend Favorite

Selective Matrix Metalloproteinase Inhibitors for Cancer

By  

Current Medicinal Chemistry, Vol. 16, Iss. 29, 2009-10 ,pp. : 3805-3827

Bentham Science Publishers

Access to resources Recommend Favorite

A novel phosphodiesterase 4 inhibitor template

By  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 6, 2003-06 ,pp. : 929-933

Informa Healthcare

Access to resources Recommend Favorite

The Activity of Matrix Metalloproteinase-9 is Part of the Mechanism of Cell-to-Cell HIV-1 Endocytosis in Dendritic Cells

By  

Current Drug Discovery Technologies, Vol. 8, Iss. 2, 2011-06 ,pp. : 112-118

Bentham Science Publishers

Access to resources Recommend Favorite